Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_assertion type Assertion NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_head.
- NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_assertion description "[Despite a growing body of evidence concerning the gene structures responsible for genetically heterogenous CMT2B and other CMT2 neuropathies, little is known about the in vitro neuropathy model and how CMT2B-associated mutation-caused aberrant neuritogenesis is properly reversed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_provenance.
- NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_assertion evidence source_evidence_literature NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_provenance.
- NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_assertion SIO_000772 20645406 NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_provenance.
- NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_assertion wasDerivedFrom befree-20150227 NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_provenance.
- NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_assertion wasGeneratedBy ECO_0000203 NP868163.RA2H4ZTdH_lkzWlljVK_yOhCtvyw3Rk4g_ypa9gEXUo-A130_provenance.